Published in Hepatology on June 01, 1999
Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol (2006) 1.60
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br J Cancer (2005) 1.45
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J Cancer Res Clin Oncol (2004) 1.12
Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems. Nat Commun (2012) 0.96
Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. J Gastroenterol (2009) 0.92
Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review). Oncol Lett (2011) 0.91
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan. Cancers (Basel) (2012) 0.89
A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP. Dig Dis Sci (2006) 0.89
Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells. BMC Cancer (2009) 0.87
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. J Gastroenterol (2010) 0.86
Current Status of Hepatic Arterial Infusion Chemotherapy. Liver Cancer (2015) 0.85
Antiproliferative effects of sorafenib and pegylated IFN‑α2b on human liver cancer cells in vitro and in vivo. Int J Oncol (2013) 0.83
Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma. Int J Clin Oncol (2010) 0.82
Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells. J Gastroenterol (2005) 0.81
Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo. PLoS One (2013) 0.80
Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells. Results Immunol (2015) 0.80
Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma. Hepatol Int (2010) 0.78
Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study. Int J Clin Oncol (2015) 0.78
Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma. Sci Rep (2015) 0.77
Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis. Exp Ther Med (2012) 0.77
Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression. Int J Cancer (2012) 0.76
Systemic combined chemotherapy with low dose of 5-fluorouracil, cisplatin, and interferon-alpha for advanced hepatocellular carcinoma: a pilot study. Dig Dis Sci (2003) 0.76
Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma. Oncotarget (2016) 0.75
Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma. Hepat Med (2011) 0.75
Antiproliferative effect of ME3738, a derivative of soyasapogenol, on hepatocellular carcinoma cell lines in vitro and in vivo. Biomed Rep (2016) 0.75
Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways. Cell Death Dis (2017) 0.75
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer (1983) 3.28
Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology (1998) 2.14
Variations of posterior vitreous detachment. Br J Ophthalmol (1997) 2.11
Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology (1999) 2.05
Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology (1992) 1.85
Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol (1998) 1.83
Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer (1982) 1.80
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology (1998) 1.75
The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol (1995) 1.74
Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer (1987) 1.73
Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med (1984) 1.40
Clinicopathologic study on clear cell hepatocellular carcinoma. Pathol Int (1996) 1.37
Epidermoid cyst of the spleen with CA19-9 or carcinoembryonic antigen productions: report of three cases. Am J Surg Pathol (1998) 1.34
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene (2006) 1.34
Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis (1986) 1.32
Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology (1989) 1.31
Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver (1999) 1.29
Development of a TT virus DNA quantification system using real-time detection PCR. J Clin Microbiol (2000) 1.29
Carcinoid tumor occurring in cystic teratoma of the kidney: a case report. Cancer (1976) 1.28
Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology (1999) 1.27
A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol (1996) 1.25
Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology (1996) 1.24
Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology (2001) 1.20
The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res (1994) 1.20
Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol (2000) 1.20
Retinal thickness measurements with optical coherence tomography and the scanning retinal thickness analyzer. Retina (2001) 1.18
Clinicopathologic features of encapsulated hepatocellular carcinoma: a study of 26 cases. Cancer (1977) 1.15
Clinical characteristics of traumatic macular holes. Jpn J Ophthalmol (1996) 1.14
Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology (1997) 1.13
Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep (2001) 1.13
Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina (1999) 1.13
Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol (1994) 1.13
Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology (1997) 1.12
Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus (2001) 1.12
Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology (1995) 1.11
Reversible expansion of primate mast cell populations in vivo by stem cell factor. J Clin Invest (1993) 1.10
Distribution of albumin- and/or alpha-fetoprotein-positive cells in hepatocellular carcinoma. Lab Invest (1981) 1.10
Comparison of the prevalence of posterior vitreous detachment in whites and Japanese. Ophthalmic Surg (1995) 1.10
Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology (1977) 1.09
Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes. Br J Ophthalmol (1995) 1.09
Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatology (1987) 1.09
Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol (1996) 1.08
Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res (1996) 1.08
Prognosis of stage 2 macular holes. Am J Ophthalmol (1995) 1.07
Expression and function of interleukin-8 in human hepatocellular carcinoma. Int J Oncol (2001) 1.07
Schwannoma of the liver: report of two surgical cases. Pathol Int (1998) 1.07
Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr (1997) 1.05
Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology (1997) 1.05
Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts? J Clin Pathol (2009) 1.05
Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res (1994) 1.05
Apocrine adenocarcinoma arising in cystic teratoma of the ovary. Arch Pathol Lab Med (1993) 1.04
Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC). Cancer (1992) 1.04
Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer (1988) 1.03
Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells. Hepatology (1993) 1.03
Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep (2000) 1.03
Effect of the vitreous on the prognosis of full-thickness idiopathic macular hole. Am J Ophthalmol (1993) 1.02
Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation. Int J Oncol (1999) 1.01
Development of a novel high power sub-THz second harmonic gyrotron. Phys Rev Lett (2009) 1.00
Direct measurement of the out-of-plane spin texture in the Dirac-cone surface state of a topological insulator. Phys Rev Lett (2011) 1.00
OCT in successful surgery of retinal detachment associated with optic nerve head pit. Ophthalmic Surg Lasers (2000) 1.00
Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis? Am J Pathol (1993) 0.99
Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma. Hepatology (2001) 0.99
Primary cutaneous meningioma. Report of a case. Acta Pathol Jpn (1987) 0.98
[Scrotum exfoliative dermatitis with ulcers associated with treatment of acute promyelocytic leukemia with all-trans retinoic acid]. Rinsho Ketsueki (1998) 0.98
Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia (2012) 0.98
Anesthesia and recovery with tricaine methanesulfonate, eugenol and thiopental sodium in the carp, Cyprinus carpio. Nihon Juigaku Zasshi (1986) 0.98
Effects of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver. Am J Physiol (1975) 0.97
Thorium dioxide-related angiosarcoma of the liver. Pathomorphologic study of 29 autopsy cases. Arch Pathol Lab Med (1985) 0.96
Expression of intercellular adhesion molecule 1 in human hepatocellular carcinoma. Hepatology (1995) 0.96
A clinical and pathological study of diffuse type hepatocellular carcinoma. Liver (1981) 0.96
Epithelioid granulomas associated with hepatocellular carcinoma. Arch Pathol Lab Med (1982) 0.95
Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. Hepatology (1996) 0.94
Collision of malignant lymphoma and multiple early adenocarcinomas of the stomach. Arch Pathol Lab Med (1989) 0.94
High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors. J Hepatol (1999) 0.93
Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology (1992) 0.93
True carcinosarcoma of the esophagus. Dis Esophagus (2006) 0.92
Spontaneous resolution of foveal detachments and macular breaks. Am J Ophthalmol (1995) 0.92
A cholangiocellular carcinoma nude mouse strain showing histologic alteration from adenocarcinoma to squamous cell carcinoma. Cancer (1992) 0.92
Scanning laser ophthalmoscope correlations with biomicroscopic findings and foveal function after macular hole closure. Arch Ophthalmol (2000) 0.92
Tylosis esophageal cancer locus on chromosome 17q25.1 is commonly deleted in sporadic human esophageal cancer. Gastroenterology (1998) 0.92
Observing the posterior vitreous by means of the scanning laser ophthalmoscope. Arch Ophthalmol (1995) 0.89
Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn J Cancer Res (1993) 0.89